These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32521907)

  • 1. Prognostic role of De Ritis and basal neutrophil to lymphocyte ratio in patients with advanced stage pancreatic cancer [Izmir Oncology Group (IZOG) Study].
    Varol U; Kaya E; Oflazoglu U; Salman T; Yildiz Y; Taskaynatan H; Saray S; Kucukzeybek Y; Alacacioglu A; Tarhan MO
    J BUON; 2020; 25(2):1063-1069. PubMed ID: 32521907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
    Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
    Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Inflammation Markers and De Ritis Ratio in Predicting Clinical Presentation and Prognosis of Patients with Testicular Germ Cell Tumors.
    Olcucu MT; Karamik K; Yilmaz K; Okuducu Y; Cakir S; Ates M
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):1041-1046. PubMed ID: 33143824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis.
    Keiner C; Meagher M; Patil D; Saito K; Walia A; Liu F; Dutt R; Miller N; Dhanji S; Saidian A; Wan F; Yasuda Y; Fujii Y; Tanaka H; Master V; Derweesh I
    Front Oncol; 2022; 12():995991. PubMed ID: 36505802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
    Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer.
    Guo J; Wu M; Guo L; Zuo Q
    Bull Cancer; 2018 Feb; 105(2):146-154. PubMed ID: 29290332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma.
    Chen Y; Yan H; Wang Y; Shi Y; Dai G
    Sci Rep; 2017 Apr; 7(1):753. PubMed ID: 28392554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of De Ritis Ratio as a Clinical Prognostic Parameter in COVID 19 Patients.
    Guzey-Aras Y; Yazar H; Acar T; Kayacan Y; Acar BA; Boncuk S; Eryilmaz HA
    Clin Lab; 2021 Oct; 67(10):. PubMed ID: 34655209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [
    Ruhwedel T; Rogasch JMM; Huang K; Jann H; Schatka I; Furth C; Amthauer H; Wetz C
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Significant Prognostic But Not Predictive Biomarker in Japanese Patients with Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel.
    Miyake H; Matsushita Y; Watanabe H; Tamura K; Suzuki T; Motoyama D; Ito T; Sugiyama T; Otsuka A
    Anticancer Res; 2018 Jul; 38(7):4179-4185. PubMed ID: 29970547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
    Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
    Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients.
    Piciucchi M; Stigliano S; Archibugi L; Zerboni G; Signoretti M; Barucca V; Valente R; Fave GD; Capurso G
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
    Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
    Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT.
    Alagappan M; Pollom EL; von Eyben R; Kozak MM; Aggarwal S; Poultsides GA; Koong AC; Chang DT
    Am J Clin Oncol; 2018 Mar; 41(3):242-247. PubMed ID: 26757436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combination of Neutrophil-to-lymphocyte Ratio and Serum Carbohydrate Antigen 19-9 Level as a Prognostic Indicator in Patients with Recurrent Pancreatic Cancer.
    Sakamoto T; Saito H; Uchinaka EI; Morimoto M; Amisaki M; Tokuyasu N; Honjo S; Ashida K; Fujiwara Y
    Anticancer Res; 2018 Sep; 38(9):5497-5503. PubMed ID: 30194208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma.
    Fang LP; Xu XY; Ji Y; Huang PW
    World J Surg; 2018 Nov; 42(11):3736-3745. PubMed ID: 30014292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
    Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
    Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
    Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
    Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy.
    Luo G; Guo M; Liu Z; Xiao Z; Jin K; Long J; Liu L; Liu C; Xu J; Ni Q; Yu X
    Ann Surg Oncol; 2015 Feb; 22(2):670-6. PubMed ID: 25155401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.